Let’s consider just four basic facts.
- The liver stores 80-90% of all vitamin A absorbed by the body.
- The liver must, and does, get fatty in response to vitamin A consumed.
- The rates and prevalence of NAFLD are so dramatically abnormal and geographically clustered, that it clearly tells us that the disease is a poisoning.
- Vitamin A is yellow.
Bonus fact: excessive vitamin A is proven to cause cirrhosis in all kinds of tissues.
What am I missing here? Has no one ever before bothered to ask the obvious question: why has that NAFLDed liver turned YELLOW?
I mean seriously, even a sixth-grader could figure this out. So, why haven’t all the brilliant minds in medical research been able to see what they are looking at? Could it be that they are blinded by all the money they make?
Big Pharma Banks on Fatty Liver Disease
With increasing rates of obesity and metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) have become increasingly common, such that they are now the most common cause of liver disease in Western countries. This has not gone unnoticed by those in the market of drug development. Where there is a disease to “treat” there is a buck to be made.